# Anthropic CEO claims AI could cure most diseases in 5-10 years > Source: > Published: 2026-08-17 19:05:59+00:00 Via axios.com # Anthropic CEO claims AI could cure most diseases in 5-10 years Dario Amodei doubles down on his boldest prediction yet, even as he concedes the AI industry hasn't delivered on its biotech promises so far Dario Amodei wants you to believe that artificial intelligence will cure most human diseases within the next decade. He also wants you to know that he understands why you might not believe him. The Anthropic CEO and co-founder posted on X on August 16 that powerful AI could lead to cures for the majority of human diseases in 5 to 10 years. But Amodei, who trained as a biophysicist before pivoting to AI, has been making this argument with increasing specificity for nearly two years. ## The thesis, and its growing credibility gap Amodei’s prediction traces back to his October 2024 essay titled “Machines of Loving Grace.” In it, he laid out a framework suggesting that sufficiently advanced AI could compress 50 to 100 years of biological and medical progress into a 5-to-10-year window. But nearly two years later, the scorecard is mixed at best. In a July 2026 interview with STAT News, Amodei himself admitted that the anticipated 10-fold increase in biotech progress has not yet materialized. Current AI models, he acknowledged, are not achieving the kind of acceleration he originally projected. ## Claude Science enters the lab Anthropic launched Claude Science on June 30, 2026, an AI tool built specifically for biological research and drug discovery. The product targets pharmaceutical companies and research biologists, with a particular focus on neglected diseases, the kind of conditions that don’t attract enough commercial interest to get traditional R&D funding. ## The trust deficit Amodei has been unusually candid about the credibility problem facing the entire AI industry. He emphasized in his STAT News interview that real results, like actually curing cancer, are crucial to counter growing public skepticism toward AI’s capabilities. Amodei acknowledged this gap directly, noting that even seasoned biologists, a group he counts himself among by training, might find his projection outrageous. ## What this actually means for medicine The traditional process of bringing a new drug to market takes roughly 10 to 15 years and costs billions. Even marginal improvements to that pipeline could save enormous amounts of time and money. **Disclosure:** This article was edited by Editorial Team. For more information on how we create and review content, see our [Editorial Policy](https://cryptobriefing.com/editorial-policy/).